MedTrace Logo

Exploring the Complex Links Between Menstrual Irregularity and Cellular Markers

NCT06339476 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2024-04-03

No results posted yet for this study

Summary

A cross-sectional study design was employed, involving 56 premenopausal participants with ages ranging from 20 to 49 years. Serum samples were collected during the early follicular phase, and levels of some biochemicals parameters analyzed.

Conditions

  • Menstrual Irregularity
  • Menstrual Cycle Abnormal

Interventions

DIAGNOSTIC_TEST

Serum ADMA, MDA and M30 levels mesurment

Blood samples collected from patienst, only 7 mL

Sponsors & Collaborators

  • Cumhuriyet University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-03-10
Completion
2024-03-24

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06339476 on ClinicalTrials.gov